Claire Villeneuve
Overview
Explore the profile of Claire Villeneuve including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
70
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Couderc S, Crepin S, Labriffe M, Monchaud C, Roussel H, Garnier A, et al.
Therapie
. 2025 Feb;
PMID: 40000276
No abstract available.
2.
Monchaud C, Humeau A, Crepin S, Kawsarani L, Villeneuve C, Etienne I, et al.
Ther Drug Monit
. 2024 Dec;
47(1):152-160.
PMID: 39626094
In transplantation, the association of tacrolimus exposure with efficacy is better known than with adverse effects. The ExpoTac study explored the relationships between tacrolimus exposure and adverse events (AEs) in...
3.
Villeneuve C, Rerolle J, Couzi L, Westeel P, Etienne I, Esposito L, et al.
Transplant Direct
. 2024 Jul;
10(8):e1678.
PMID: 39076520
Background: In kidney transplant recipients with positive serology (R+) for the cytomegalovirus (CMV), 2 strategies are used to prevent infection, whose respective advantages over the other are still debated. This...
4.
Couderc S, Crepin S, Labriffe M, Monchaud C, Roussel H, Garnier A, et al.
Therapie
. 2024 Jul;
79(6):730-736.
PMID: 38964941
No abstract available.
5.
Villeneuve C, Humeau A, Monchaud C, Labriffe M, Rerolle J, Couzi L, et al.
Clin Pharmacol Ther
. 2024 Feb;
116(2):351-362.
PMID: 38372185
The clinical impact of individual dose adjustment of mycophenolate mofetil is still debated, due to conflicting results from randomized clinical trials. This retrospective study aimed to compare 3-year rejection-free survival...
6.
Monchaud C, Villeneuve C, Belaiche S, Charbit M, Colosio C, Houssel P, et al.
Transplantation
. 2023 Feb;
107(3):549-553.
PMID: 36808841
No abstract available.
7.
Villeneuve C, Rerolle J, Couzi L, Westeel P, Etienne I, Esposito L, et al.
Transpl Int
. 2021 Sep;
34(11):2341-2352.
PMID: 34585793
Patients are not always aware of the inconveniences associated with renal transplantation, which they compare with a « rebirth », and from which they expect complete recovery. Therapeutic education is...
8.
Petitpain N, Olivier P, Crepin S, Leone E, Ouk T, Villeneuve C, et al.
Therapie
. 2021 May;
76(6):743-750.
PMID: 33993991
Purpose: To follow the European Directive 2001/20/EC, institutional sponsors created or reinforced their vigilance units. Since 2007, the working group "REflexion sur la VIgilance et la Sécurité des Essais" (REVISE)...
9.
Roux B, Sirois C, Niquille A, Spinewine A, Ouellet N, Petein C, et al.
Res Social Adm Pharm
. 2020 Dec;
17(8):1453-1462.
PMID: 33317980
Background: The revised Patients' Attitudes Towards Deprescribing (rPATD) questionnaire allows capture of the beliefs and attitudes of older adults and caregivers towards deprescribing. Objectives: To translate and validate the rPATD...
10.
Villeneuve C, Rousseau A, Rerolle J, Couzi L, Kamar N, Essig M, et al.
Patient Educ Couns
. 2019 Aug;
103(1):189-198.
PMID: 31447197
Objective: Adherence is a dynamic phenomenon and a critical determinant of transplant patients outcome. The objective of this longitudinal study was to explore adherence in kidney transplant patients followed-up for...